Unknown PHASE1 INTERVENTIONAL 2-arm NCT03251287

Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

Mechanistic Study of the Effect of Inorganic Sodium Nitrate on Cardiac and Skeletal Muscle Metabolic Efficiency in Patients With Hypertrophic Cardiomyopathy

Sponsor: British Medical Research Council

Conditions Cardiomyopathy, Hypertrophic

Interventions Exercise Stress Transthoracic Echocardiogram Phosphorous Magnetic Resonance Spectroscopy Placebo Sodium Nitrate

Updated 6 times since 2017 Last updated: Oct 24, 2017 Started: Nov 30, 2017 Primary completion: Dec 31, 2018 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cardiomyopathy, Hypertrophic, this trial is ongoing. The trial is conducted by British Medical Research Council and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

British Medical Research Council
Norfolk and Norwich University Hospitals NHS Foundation Trust
University of East Anglia

Data source: University of East Anglia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Norwich, United Kingdom